26.50EUR+0.38%Mkt Cap: —P/E: 16.261d ago
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, i…
Industry Peers
Healthcare$1.14TUSDP/E 43.0
$658.89BUSDP/E 31.7
$462.68BUSDP/E 74.0
$345.19BUSDP/E 24.7
$375.50BUSDP/E 122.7
$348.81BUSDP/E 25.0
$283.47BUSDP/E 22.7
$276.41BUSDP/E 23.7
$234.02BUSDP/E 25.0
$240.45BUSDP/E 24.5
$238.75BUSDP/E 27.4
$226.85BUSDP/E 33.1
$190.75BUSDP/E 11.3
$198.81BUSDP/E 36.9
$183.02BUSD
$160.96BUSDP/E 37.2
$142.58BUSDP/E 38.5
$151.78BUSDP/E 38.6
$142.49BUSDP/E 45.6
$130.23BUSDP/E 32.1
Key Statistics
Company
Market Cap—
Enterprise Value448.12M $
Revenue (TTM)544.68M $
Gross Profit397.53M $
Net Income (TTM)35.48M $
Revenue/Share31.37 USD
Last Price26.50 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.4K
CountryGB
SectorHealthcare
Industry—
ISIN—
Valuation
P/E (Trailing)16.26
P/E (Forward)—
PEG—
EV/EBITDA5.96
EV/Revenue0.82
P/S—
P/B1.17
EPS (TTM)1.63
EPS (Forward)—
52W Range
26.20100% of range26.50
52W High26.50 EUR
52W Low26.20 EUR
Profitability
Gross Margin72.98%
Oper. Margin11.60%
EBITDA Margin13.80%
Profit Margin6.51%
ROE8.47%
ROA5.47%
Growth
Revenue Growth-1.40%
Earnings Growth165.90%
Cash Flow & Leverage
Operating CF57.87M $
CapEx (TTM)—
FCF Margin10.59%
FCF Yield—
Net Debt-52.02M $
Net Debt/EBITDA-0.69
Balance Sheet
Debt/Equity8.02
Current Ratio2.22
Quick Ratio1.43
Book Value/Sh22.62 EUR
Cash/Share4.569 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate1.350 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.17.60M
Float3.50M
Insiders79.00%
Institutions5.37%
Technical
SMA 5038.13 (-30.5%)
SMA 20044.05 (-39.8%)
Beta0.22
S&P 52W Chg18.16%
Avg Vol (30d)1
Avg Vol (10d)311
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—